-
Aclaris Therapeutics to Attend Upcoming Investor Conferences
-
Aclaris Therapeutics to Attend Upcoming Investor Conferences
-
Aclaris Therapeutics to Attend Upcoming Investor Conferences
-
Citi Starts Aclaris Therapeutis (ACRS) at Buy
-
Aclaris Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Aclaris Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Aclaris Therapeutics (ACRS) IPO Opens 9% Higher
-
Aclaris Therapeutics (ACRS) IPO Prices at $11, Well Below Expected Range
-
Aclaris Announces Pricing of Initial Public Offering
-
Aclaris Announces Pricing of Initial Public Offering
-
Aclaris Therapeutics (ACRS) Files $86.25M Common Stock IPO

